Open AccessChemotherapy related myocardial infarction in a young patient with yolk sac tumor
Author(s) -
Hayri Alıcı,
Fethi Yavuz,
Süleyman Ercan,
Vedat Davutoğlu
Publication year - 2015
Publication title -
international journal of the cardiovascular academy
Language(s) - English
Resource type - Journals
eISSN - 2618-6012
pISSN - 2405-8181
DOI - 10.1016/j.ijcac.2015.07.010
Subject(s) - medicine , myocardial infarction , chemotherapy , etoposide , bleomycin , tissue plasminogen activator , yolk sac , cardiology , cisplatin , surgery , oncology , embryo , biology , microbiology and biotechnology
Chemotherapy related myocardial infarction is rare but can be life-threatening. Herein, we present a 24-year-old yolk-sac tumor patient admitted to the emergency department with acute myocardial infarction. The patient had received the third cycle of combined chemotherapy with bleomycin, etoposide and cisplatin for days ago. Electrocardiogram showed acute anterior myocardial infarction and the patient was treated successfully with tissue plasminogen activator. To the best of our knowledge, this is the first case which was treated with fibrinolytic therapy in a patient with chemotherapy related myocardial infarction in literature. Cancer chemotherapy may be complicated by acute coronary events and physicians should assess cautiously patients according to their coronary symptoms and risk factors before and during chemotherapy